FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386215483> ?p ?o ?g. }

• W4386215483 endingPage "e0011584" @default.
• W4386215483 startingPage "e0011584" @default.
• W4386215483 abstract "There is a lack of systematic evidence for strategies to control loiasis transmission in highly endemic regions. Here we assessed albendazole and ivermectin based treatment regimens to reduce Loa loa microfilaraemia in Gabon.Eligible adult patients with L. loa microfilaraemia between 5,000 and 50,000 microfilariae/ml were randomized to either a control or one of three intervention groups (1:2:2:2 allocation ratio) consisting of three-week twice daily 400mg oral albendazole followed by 1) no treatment, 2) two further weeks of twice daily 400mg albendazole, or 3) a single dose of ivermectin in this open label randomized assessor blinded controlled clinical trial. The primary outcome was the proportion of participants with L. loa microfilaraemia ≤ 100 mf/ml at Day 168.In the efficacy-population of 42 patients 0 (0%; control group), 1 (9%; 3-week albendazole), 5 (39%; 5-weeks albendazole) and 2 (22%; 3-week albendazole plus single dose ivermectin) participants met the primary outcome of microfilaraemia below 100/ml at day 168. A 80-90% reduction of microfilaraemia was observed in the active treatment groups.The 5-week regimen of albendazole or a 3-week regimen of albendazole followed by ivermectin were most efficacious to reduce microfilaraemia. All therapeutic regimens were well tolerated and safe.Trial registered at the Pan-African Clinical Trials Registry: PACTR201807197019027." @default.
• W4386215483 created "2023-08-29" @default.
• W4386215483 creator A5005365222 @default.
• W4386215483 creator A5006867186 @default.
• W4386215483 creator A5009319293 @default.
• W4386215483 creator A5011202603 @default.
• W4386215483 creator A5013340768 @default.
• W4386215483 creator A5016807927 @default.
• W4386215483 creator A5027782628 @default.
• W4386215483 creator A5031546052 @default.
• W4386215483 creator A5068676548 @default.
• W4386215483 creator A5069169948 @default.
• W4386215483 creator A5076100025 @default.
• W4386215483 creator A5088720377 @default.
• W4386215483 creator A5090444000 @default.
• W4386215483 creator A5092811408 @default.
• W4386215483 creator A5092811409 @default.
• W4386215483 creator A5092811410 @default.
• W4386215483 date "2023-08-28" @default.
• W4386215483 modified "2023-10-18" @default.
• W4386215483 title "Efficacy, safety, and tolerability of albendazole and ivermectin based regimens for the treatment of microfilaraemic loiasis in adult patients in Gabon: A randomized controlled assessor blinded clinical trial" @default.
• W4386215483 cites W1759253278 @default.
• W4386215483 cites W1830017950 @default.
• W4386215483 cites W1979411419 @default.
• W4386215483 cites W1991496259 @default.
• W4386215483 cites W2002266144 @default.
• W4386215483 cites W2013660563 @default.
• W4386215483 cites W2019925804 @default.
• W4386215483 cites W2043906497 @default.
• W4386215483 cites W2053546135 @default.
• W4386215483 cites W2084747469 @default.
• W4386215483 cites W2093274439 @default.
• W4386215483 cites W2125756704 @default.
• W4386215483 cites W2130914472 @default.
• W4386215483 cites W2149086938 @default.
• W4386215483 cites W2255808366 @default.
• W4386215483 cites W2295801842 @default.
• W4386215483 cites W2343368844 @default.
• W4386215483 cites W2581613095 @default.
• W4386215483 cites W2782894713 @default.
• W4386215483 cites W2801314994 @default.
• W4386215483 cites W2898806417 @default.
• W4386215483 cites W2955219357 @default.
• W4386215483 cites W3036041336 @default.
• W4386215483 cites W3091873844 @default.
• W4386215483 cites W3094014261 @default.
• W4386215483 cites W3120734871 @default.
• W4386215483 cites W3194965676 @default.
• W4386215483 cites W4243936225 @default.
• W4386215483 doi "https://doi.org/10.1371/journal.pntd.0011584" @default.
• W4386215483 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37639396" @default.
• W4386215483 hasPublicationYear "2023" @default.
• W4386215483 type Work @default.
• W4386215483 citedByCount "0" @default.
• W4386215483 crossrefType "journal-article" @default.
• W4386215483 hasAuthorship W4386215483A5005365222 @default.
• W4386215483 hasAuthorship W4386215483A5006867186 @default.
• W4386215483 hasAuthorship W4386215483A5009319293 @default.
• W4386215483 hasAuthorship W4386215483A5011202603 @default.
• W4386215483 hasAuthorship W4386215483A5013340768 @default.
• W4386215483 hasAuthorship W4386215483A5016807927 @default.
• W4386215483 hasAuthorship W4386215483A5027782628 @default.
• W4386215483 hasAuthorship W4386215483A5031546052 @default.
• W4386215483 hasAuthorship W4386215483A5068676548 @default.
• W4386215483 hasAuthorship W4386215483A5069169948 @default.
• W4386215483 hasAuthorship W4386215483A5076100025 @default.
• W4386215483 hasAuthorship W4386215483A5088720377 @default.
• W4386215483 hasAuthorship W4386215483A5090444000 @default.
• W4386215483 hasAuthorship W4386215483A5092811408 @default.
• W4386215483 hasAuthorship W4386215483A5092811409 @default.
• W4386215483 hasAuthorship W4386215483A5092811410 @default.
• W4386215483 hasBestOaLocation W43862154831 @default.
• W4386215483 hasConcept C126322002 @default.
• W4386215483 hasConcept C141071460 @default.
• W4386215483 hasConcept C165901193 @default.
• W4386215483 hasConcept C168563851 @default.
• W4386215483 hasConcept C197934379 @default.
• W4386215483 hasConcept C203014093 @default.
• W4386215483 hasConcept C2776031002 @default.
• W4386215483 hasConcept C2776908094 @default.
• W4386215483 hasConcept C2777065887 @default.
• W4386215483 hasConcept C2777411658 @default.
• W4386215483 hasConcept C2777499811 @default.
• W4386215483 hasConcept C2777629521 @default.
• W4386215483 hasConcept C2778375690 @default.
• W4386215483 hasConcept C2781413609 @default.
• W4386215483 hasConcept C42972112 @default.
• W4386215483 hasConcept C535046627 @default.
• W4386215483 hasConcept C71924100 @default.
• W4386215483 hasConceptScore W4386215483C126322002 @default.
• W4386215483 hasConceptScore W4386215483C141071460 @default.
• W4386215483 hasConceptScore W4386215483C165901193 @default.
• W4386215483 hasConceptScore W4386215483C168563851 @default.
• W4386215483 hasConceptScore W4386215483C197934379 @default.
• W4386215483 hasConceptScore W4386215483C203014093 @default.
• W4386215483 hasConceptScore W4386215483C2776031002 @default.
• W4386215483 hasConceptScore W4386215483C2776908094 @default.
• W4386215483 hasConceptScore W4386215483C2777065887 @default.

• next